- Home
- NODK vs OSUR Comparison
NODK vs OSUR Comparison
Compare NODK & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NODK
- OSUR
- Stock Information
- Founded
- NODK 1946
- OSUR 2000
- Country
- NODK United States
- OSUR United States
- Employees
- NODK N/A
- OSUR N/A
- Industry
- NODK Property-Casualty Insurers
- OSUR Medical/Dental Instruments
- Sector
- NODK Finance
- OSUR Health Care
- Exchange
- NODK Nasdaq
- OSUR Nasdaq
- Market Cap
- NODK 290.9M
- OSUR 266.7M
- IPO Year
- NODK 2017
- OSUR 1986
- Fundamental
- Price
- NODK $14.16
- OSUR $3.51
- Analyst Decision
- NODK
- OSUR Hold
- Analyst Count
- NODK 0
- OSUR 2
- Target Price
- NODK N/A
- OSUR $5.50
- AVG Volume (30 Days)
- NODK 19.8K
- OSUR 1.0M
- Earning Date
- NODK 03-07-2025
- OSUR 05-07-2025
- Dividend Yield
- NODK N/A
- OSUR N/A
- EPS Growth
- NODK N/A
- OSUR N/A
- EPS
- NODK N/A
- OSUR N/A
- Revenue
- NODK $325,204,000.00
- OSUR $185,827,000.00
- Revenue This Year
- NODK N/A
- OSUR N/A
- Revenue Next Year
- NODK N/A
- OSUR $8.41
- P/E Ratio
- NODK $45.52
- OSUR N/A
- Revenue Growth
- NODK 6.97
- OSUR N/A
- 52 Week Low
- NODK $13.47
- OSUR $2.69
- 52 Week High
- NODK $17.24
- OSUR $6.69
- Technical
- Relative Strength Index (RSI)
- NODK 46.10
- OSUR 48.07
- Support Level
- NODK $13.91
- OSUR $3.40
- Resistance Level
- NODK $14.30
- OSUR $3.64
- Average True Range (ATR)
- NODK 0.35
- OSUR 0.17
- MACD
- NODK 0.01
- OSUR 0.02
- Stochastic Oscillator
- NODK 30.84
- OSUR 62.26
About NODK NI Holdings Inc.
NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.